PetMed Express, Inc. (NASDAQ:PETS) Position Increased by Aperio Group LLC
Aperio Group LLC increased its position in shares of PetMed Express, Inc. (NASDAQ:PETS) by 25.5% during the second quarter, Holdings Channel reports. The institutional investor owned 30,918 shares of the company’s stock after buying an additional 6,278 shares during the period. Aperio Group LLC’s holdings in PetMed Express were worth $1,255,000 at the end of the most recent reporting period.
Other hedge funds also recently modified their holdings of the company. Dimensional Fund Advisors LP increased its stake in PetMed Express by 20.7% in the fourth quarter. Dimensional Fund Advisors LP now owns 640,960 shares of the company’s stock valued at $14,787,000 after buying an additional 109,730 shares during the last quarter. Teachers Advisors LLC increased its stake in PetMed Express by 11.8% in the fourth quarter. Teachers Advisors LLC now owns 60,787 shares of the company’s stock valued at $1,402,000 after buying an additional 6,426 shares during the last quarter. Fisher Asset Management LLC increased its stake in PetMed Express by 43.5% in the first quarter. Fisher Asset Management LLC now owns 86,359 shares of the company’s stock valued at $1,739,000 after buying an additional 26,195 shares during the last quarter. Cardinal Capital Management increased its stake in PetMed Express by 1.8% in the first quarter. Cardinal Capital Management now owns 18,522 shares of the company’s stock valued at $373,000 after buying an additional 322 shares during the last quarter. Finally, New Jersey Better Educational Savings Trust purchased a new stake in PetMed Express during the first quarter valued at $504,000. 79.12% of the stock is owned by hedge funds and other institutional investors.
PetMed Express, Inc. (PETS) traded down 0.13% during mid-day trading on Monday, hitting $47.70. The company had a trading volume of 148,786 shares. PetMed Express, Inc. has a 52-week low of $18.90 and a 52-week high of $50.90. The company has a market capitalization of $967.93 million, a P/E ratio of 36.69 and a beta of 0.99. The company has a 50-day moving average price of $43.59 and a 200 day moving average price of $30.19.
PetMed Express (NASDAQ:PETS) last announced its quarterly earnings data on Monday, July 24th. The company reported $0.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.38 by $0.07. The business had revenue of $79.66 million during the quarter, compared to analysts’ expectations of $77.32 million. PetMed Express had a return on equity of 28.67% and a net margin of 10.34%. The business’s quarterly revenue was up 9.9% compared to the same quarter last year. During the same quarter last year, the business posted $0.32 EPS. On average, analysts forecast that PetMed Express, Inc. will post $1.44 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 18th. Stockholders of record on Monday, August 7th will be paid a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 1.68%. The ex-dividend date of this dividend is Thursday, August 3rd. PetMed Express’s payout ratio is presently 61.54%.
Several research firms recently weighed in on PETS. Northcoast Research upgraded PetMed Express from a “neutral” rating to a “buy” rating and set a $54.00 price objective for the company in a report on Monday, July 24th. Zacks Investment Research upgraded PetMed Express from a “hold” rating to a “strong-buy” rating and set a $38.00 price objective for the company in a report on Wednesday, May 10th. Noble Financial restated a “hold” rating on shares of PetMed Express in a report on Wednesday, July 26th. Finally, Craig Hallum downgraded PetMed Express from a “buy” rating to a “hold” rating in a report on Tuesday, July 11th. One analyst has rated the stock with a sell rating, two have given a hold rating, one has assigned a buy rating and one has issued a strong buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus price target of $35.00.
In other news, Director Frank J. Formica sold 5,000 shares of the firm’s stock in a transaction dated Tuesday, May 16th. The stock was sold at an average price of $35.32, for a total transaction of $176,600.00. Following the sale, the director now owns 46,000 shares of the company’s stock, valued at approximately $1,624,720. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Bruce S. Rosenbloom sold 6,833 shares of the firm’s stock in a transaction dated Thursday, July 27th. The stock was sold at an average price of $50.18, for a total value of $342,879.94. Following the sale, the chief financial officer now directly owns 18,534 shares in the company, valued at approximately $930,036.12. The disclosure for this sale can be found here. Insiders sold a total of 24,333 shares of company stock valued at $1,126,330 in the last quarter. Company insiders own 4.00% of the company’s stock.
PetMed Express Company Profile
PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.
Want to see what other hedge funds are holding PETS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for PetMed Express, Inc. (NASDAQ:PETS).
Receive News & Ratings for PetMed Express Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.